Pay in 4 interest-free payments of $6.33 Learn more
Ships within 48 hours · Estimated delivery Oct 26 - Oct 31
The dietary supplement industry keeps expanding and gives us easy access to all sorts of products to support our general health and wellbeing
doi: 10.1016/j.annonc.2021.05.801
Schurhoff, N
Secondary objectives were change from baseline to week 3 for tirzepatide versus placebo in fasting and postprandial appetite VAS ratings, FCI, FCQ-S, Eating Inventory, PFS questionnaire ratings and BOLD activation to photos of Food HiPal (Food HiF/HiS and Food HiF/HiC ) relative to non-food during the fasting state in the prespecified principal reward ROIs
Learning Objectives: List the two types of glucagon-like peptide-1 (GLP-1) medications approved for weight loss Describe the proposed mechanism of action for GLP-1s and glucose-dependent insulinotropic peptide (GIP) medications Explain where GLP receptors are found List three data points on efficacy outcomes of GLP-1s List five main side effects of GLP-1s Explain the relationship between GLP dose and side effects Describe what mindful eating is and how it can be used to help optimize nutritional status and ameliorate the side effects of GLP-1s List three pieces of motivational interviewing (MI) dialogue to help assess the impact of a GLP-1 to inform the counseling focus Using Mindful Eating with GLP-1 Medications webinar presents the benefits of coupling a mindful eating approach with weight loss medication for personalized and effective care
